The clinical and public health problem of relapse despite primaquine therapy: case review of repeated relapses of Plasmodium vivax acquired in Papua New Guinea
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1475-2875
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
The clinical and public health problem of relapse despite primaquine therapy: case review of repeated relapses of Plasmodium vivax acquired in Papua New Guinea ; volume:13 ; number:1 ; day:12 ; month:12 ; year:2014 ; pages:1-7 ; date:12.2014
Malaria journal ; 13, Heft 1 (12.12.2014), 1-7, 12.2014
- Creator
-
Ingram, R Joan H.
- Contributor
-
Crenna-Darusallam, Chelzie
Soebianto, Saraswati
Noviyanti, Rintis
Baird, J Kevin
SpringerLink (Online service)
- DOI
-
10.1186/1475-2875-13-488
- URN
-
urn:nbn:de:1111-2016080648012
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:46 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Ingram, R Joan H.
- Crenna-Darusallam, Chelzie
- Soebianto, Saraswati
- Noviyanti, Rintis
- Baird, J Kevin
- SpringerLink (Online service)
Other Objects (12)
Increased primaquine total dose prevents Plasmodium vivax relapses in patients with impaired CYP2D6 activity: report of three cases
Several Plasmodium vivax relapses after correct primaquine treatment in a patient with impaired cytochrome P450 2D6 function
Genetic variability of Plasmodium vivax from primary–relapses paired samples
Primaquine radical cure of Plasmodium vivax: a critical review of the literature
Safety of primaquine in infants with Plasmodium vivax malaria in Papua, Indonesia
Natural relapses in vivax malaria induced by Anopheles mosquitoes
Primaquine 30 mg/day versus 15 mg/day during 14 days for the prevention of Plasmodium vivax relapses in adults in French Guiana: a historical comparison
Development of weight and age-based dosing of daily primaquine for radical cure of vivax malaria
Neurodegeneration progresses despite complete elimination of clinical relapses in a mouse model of multiple sclerosis
Relapse of imported Plasmodium vivax malaria is related to primaquine dose: a retrospective study
Therapeutic efficacy of chloroquine and primaquine for Plasmodium vivax malaria treatment in southeast Iran
Primaquine in vivax malaria: an update and review on management issues
Increased primaquine total dose prevents Plasmodium vivax relapses in patients with impaired CYP2D6 activity: report of three cases
Several Plasmodium vivax relapses after correct primaquine treatment in a patient with impaired cytochrome P450 2D6 function
Genetic variability of Plasmodium vivax from primary–relapses paired samples
Primaquine radical cure of Plasmodium vivax: a critical review of the literature
Safety of primaquine in infants with Plasmodium vivax malaria in Papua, Indonesia
Natural relapses in vivax malaria induced by Anopheles mosquitoes
Primaquine 30 mg/day versus 15 mg/day during 14 days for the prevention of Plasmodium vivax relapses in adults in French Guiana: a historical comparison
Development of weight and age-based dosing of daily primaquine for radical cure of vivax malaria
Neurodegeneration progresses despite complete elimination of clinical relapses in a mouse model of multiple sclerosis
Relapse of imported Plasmodium vivax malaria is related to primaquine dose: a retrospective study
Therapeutic efficacy of chloroquine and primaquine for Plasmodium vivax malaria treatment in southeast Iran
Primaquine in vivax malaria: an update and review on management issues
Increased primaquine total dose prevents Plasmodium vivax relapses in patients with impaired CYP2D6 activity: report of three cases
Several Plasmodium vivax relapses after correct primaquine treatment in a patient with impaired cytochrome P450 2D6 function
Genetic variability of Plasmodium vivax from primary–relapses paired samples
Primaquine radical cure of Plasmodium vivax: a critical review of the literature
Safety of primaquine in infants with Plasmodium vivax malaria in Papua, Indonesia
Natural relapses in vivax malaria induced by Anopheles mosquitoes
Primaquine 30 mg/day versus 15 mg/day during 14 days for the prevention of Plasmodium vivax relapses in adults in French Guiana: a historical comparison
Development of weight and age-based dosing of daily primaquine for radical cure of vivax malaria
Neurodegeneration progresses despite complete elimination of clinical relapses in a mouse model of multiple sclerosis
Relapse of imported Plasmodium vivax malaria is related to primaquine dose: a retrospective study
Therapeutic efficacy of chloroquine and primaquine for Plasmodium vivax malaria treatment in southeast Iran